“The work of Childhood Dementia Initiative is incredibly important. It is raising awareness of childhood dementia and leading the charge to find treatments for children where very few currently exist. I am very pleased to contribute to this valuable initiative.”
James brings to Childhood Dementia Initiative's Strategic Advisory Group extensive experience in healthcare gained from senior executive roles and Board directorships in the pharmaceutical industry. This spans global, US and local businesses across rare disease, speciality care, primary care and Over the Counter (OTC) markets. James is also experienced in working with government and key policymakers and providing input to future health policies for long term industry sustainability.
Most recently, James was Managing Director of the pharmaceutical company, Takeda Australia. He led the transformation of the business from primary care to a speciality care and rare disease business. Before joining Takeda, James was the Director of Primary Care for Schering Plough Australia and served in senior roles with Sanofi-Synthelabo in Australia and overseas. His Board Directorships include 6 years with Medicines Australia (with 4 as Chair of the Finance subcommittee) and 7 years with CHP (Consumer Health Products) Australia. James is also a founding member of the not-for-profit Better Access Australia, which strives for improvements in health, disability, and social services for all Australians.
Today, James draws on his experience as a consultant. He advises in areas including leadership, management, strategic planning, product launch, branding and life cycle management, stakeholder management, change management and restructures.